North Carolina has recovered $15.8 million from Abbott Laboratories as part of a national fraud settlement involving the drug Depakote, state Attorney General Roy Cooper announced Monday.
The funds are part of a $1.5 billion national settlement to resolve allegations that Abbott illegally marketed Depakote. Depakote is approved by the U.S. Food and Drug Administration to treat seizures and mania associated with bipolar disorder and to prevent migraines.
Cooper and other states involved in the settlement contend that from January 1998 through December 31, 2008, Abbott promoted Depakote for uses that were not approved by the FDA as safe and effective. This resulted in false claims to Medicaid and other taxpayer-funded health care programs.
Of the $15.8 million recovered by North Carolina from Abbott, $917,553.61 will go to the state’s public schools. The remaining funds will go to support Medicaid efforts in the state.
Cooper’s office won a separate $3.7 million from Abbott in May to resolve similar allegations.